Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. Updated 2020. GINA Science Committee. Chair: Helen Reddel, MBBS PhD. GINA Board of Directors. Chair: Louis-Philippe Boulet, MD. GINA Dissemination and Implementation Committee. Chair: Mark Levy, MD (to Sept 2019); Alvaro Cruz, MD (from Sept 2019) GINA Assembly.

  2. Once asthma is well-controlled, the maintenance dose should be adjusted to the lowest dose at which effective control of asthma is maintained. For some adults and adolescents, this can be achieved by reducing the maintenance dose to once daily.

  3. Treatment: One regimen used in two reviewed studies is budesonide inhalation suspension, 1 mg twice daily for 7 days at the first sign of respiratory tract infection-associated symptoms. Potential benefits: The main benefit during respiratory tract infections is a reduction in exacerbations requiring systemic corticosteroids.

  4. Asthma medicines cannot cure asthma, but they can address and help improve your symptoms. Your doctor will most likely recommend that you use specific medication (and dosage) based on a number...

  5. The intensity of treatment depends on severity of symptoms: up to 3 treatments at 20-minute intervals as needed. In Steps 3 and 4, the preferred option includes the use of ICS-formoterol 1 to 2 pufs as needed up to a maximum total daily maintenance and rescue dose of 8 pufs (36 mcg). .

  6. The occasional use of over-the-counter (OTC) epinephrine inhalers appears to be safe and effective when used according to labeled instruction by individuals with mild, intermittent asthma. However, gross misuse of these products can cause severe adverse reactions, including death.

  7. 1 Ιουν 2018 · Inhaled β 2 agonists are classified based on the duration of their effect: short-acting β 2 agonists and long-acting β 2 agonists. Albuterol, a short-acting β 2 agonist, is the most widely used bronchodilator for the treatment of acute asthma. It has a half-life of 4–6 h and rapid onset of action.

  1. Γίνεται επίσης αναζήτηση για